Utter Christine Marie's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Mar 31, 2023
- Accession no.
- 0001415889-23-005666
- Filed
- Mar 31, 2023
- Trade date
- Mar 29, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $224.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Utter Christine MarieCIK 0001707685 | Officer (SVP, FINANCE & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Common Stock | MOption exerciseAcquired | +4,688 | $40.45 | +$189,629.6 | 42,747 | Direct | |
| Mar 29, 2023 | Common Stock | SSaleDisposed | −3,247 | $47.80F2 | −$155,206.6 | 39,500 | Direct | |
| Mar 29, 2023 | Common Stock | SSaleDisposed | −1,441 | $47.78F2 | −$68,850.98 | 38,059 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2023 | Common Stock | MOption exerciseDisposed | −4,688 | $40.45 | −$189,629.6 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $47.50 to $48.285 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.